3 unknown. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Unknown 3 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases T cell injection targeting CD19 chimeric antigen receptor - Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies | Early Phase 1 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2024-05-14 | 2024-05-16 |
| A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma Assigned Interventions CD19/BCMA CAR T-cells - Scleroderma, Autoimmune Diseases | Early Phase 1 | Unknown | Zhejiang University | 9 | 2021-10-08 | 2021-10-20 |
| The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc ) Methylprednisolone, sodium chloride - Systemic Sclerosis, Raynaud Phenomena | Early Phase 1 | Unknown | Radboud University Medical Center | 30 | 2017-01-01 | 2019-11-29 |
Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Liver Cirrhosis, Biliary (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Scleroderma, Diffuse (1) · Sjogren's Syndrome (1)
Connective Tissue Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Immune System Diseases (2) · Arthritis (1) · Autoimmune Diseases (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Cholestasis (1) · Cholestasis, Intrahepatic (1) · Cytopenia (1) · Digestive System Diseases (1) · Dry Eye Syndromes (1)
Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Sodium Chloride (1)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1) · Radboud University Medical Center (1) · Zhejiang University (1)
China (1) · Netherlands (1)
He Huang, PhD (1) · Madelon Vonk, Dr. (1)